The SLC6A1 gene helps brain cells clear away GABA, a calming chemical messenger, after signals are sent. If it does not work well, brain signaling can become poorly balanced, which may lead to seizures, developmental delay, learning difficulties, movement differences, or autistic features. Many people with variants in the SLC6A1 gene are identified in childhood. Day to day effects vary, and some people are more affected than others.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do the work. Other genes mainly regulate when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in LearnHub.
Overview
SLC6A1Gene function
What if the gene works
The SLC6A1 gene helps brain cells recycle GABA, a chemical messenger that quiets nerve activity. This helps keep signaling more balanced and supports normal brain function.
Risk
What if the gene does not work
Variants in the SLC6A1 gene often affect brain signaling and can cause epilepsy, developmental delay, learning problems, and sometimes autism or movement differences. Milder to more severe variants may influence when symptoms begin and how much support a person needs.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided by a proven, disease specific approach for pathogenic variants in the SLC6A1 gene. The SLC6A1 gene is being studied as a treatment target, including 4 phenylbutyrate and gene based approaches aimed at improving GABA transporter function.
Conditions associated with SLC6A1
Gene function
What if the gene works
In the brain, the SLC6A1 gene helps manage GABA, a calming chemical messenger. It supports precise timing of nerve cell signals so messages do not linger longer than needed. Understanding what the SLC6A1 gene does in the brain helps explain steady, well controlled communication between nerve cells.
The SLC6A1 gene makes a transporter protein that moves GABA back into nerve cells and nearby support cells after it is released. This clears extra messenger from the space between cells.
By removing GABA at the right time, this gene helps calming signals end in a controlled way. That lets nearby nerve cells get ready for the next message.
Cells can reuse some of the GABA that is taken back up. This supports a steady supply of the messenger for day to day brain activity.
Across brain networks, the transporter from the SLC6A1 gene helps keep calming activity in balance with activating activity. This supports smooth communication during tasks like attention, learning, and sleep.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the SLC6A1 gene make the GAT-1 protein unstable, misfolded, or poorly moved to the cell surface, so cells take up less GABA (a calming brain messenger). How SLC6A1 variants affect gene function can range from a mild drop in transport activity to little or no working protein, including with truncating variants. This loss of function can vary from partial to more severe, and stronger disruption is often linked to earlier onset and more marked neurologic features.
How variants are linked to conditions
Pathogenic variants in the SLC6A1 gene cause a condition often called SLC6A1-related neurodevelopmental disorder. These SLC6A1 gene variants are linked to epilepsy and developmental delay. Many affected people also have speech and learning difficulties, and some have autism features, low muscle tone, attention problems, or movement differences.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and occur commonly across the general population. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences also play a part. In other situations, one well-characterized variant in a particular gene may be enough to establish the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the SLC6A1 gene. In families with a disease-causing SLC6A1 change, the gene change itself is usually the main reason for the condition, while symptoms can still vary from one person to another.
Inheritance of SLC6A1 variants
SLC6A1-related conditions usually follow an autosomal dominant inheritance pattern, which means one altered copy of the SLC6A1 gene can be enough to cause the condition. In families wondering how variants of the SLC6A1 gene are inherited, an affected parent has a 50% chance of passing the variant to each child. Many people with an SLC6A1-related condition have a new (de novo) variant that was not inherited from either parent. When the variant is inherited, it can be passed from a mother or a father to sons or daughters equally.
What does my SLC6A1 result mean for my family?
For many living with an SLC6A1-related condition, the gene change follows a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry it and may want to discuss family testing. In some families, the change is new in the affected child and is not found in either parent, so it does not always come from a parent. The meaning for relatives depends on the exact result found in your family.
Genetic information
Genetic testing
How you find out about variants
Doctors look for changes in the SLC6A1 gene with genetic testing for SLC6A1 variants, usually using a blood or saliva sample. A lab reads the DNA code and compares it with the usual sequence to see whether a variant is present and whether it is known to help explain a person’s symptoms.
When should I consider getting a genetic test?
Consider genetic testing for the SLC6A1 gene if a child or adult has epilepsy, especially seizures that start early in life, together with developmental delay, learning difficulties, autism, or unusual movements. Testing can also be helpful when these features appear in more than one family member.
A genetic result is only one part of your health story
Genetic test results can give useful information, but what they reveal depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same medicine may work well for one person, have less effect for another, or cause more side effects in someone else. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences affect the way people respond to medicines. It looks at relationships between genes and medications to help explain why the same treatment may work differently from one person to another. With many drugs, genes can influence how strong a medicine’s effect is or how the body handles it. This information can support better informed, more personalized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC6A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or symptom changes are best discussed with your doctor. SLC6A1 has been studied in epilepsy because it affects a brain chemical transporter that some seizure medicines act on, but this has not led to routine prescribing guidance.
History
The SLC6A1 gene entered medical research through studies of brain signaling in the 1990s, when scientists identified it as part of a larger family of transport genes. In recent decades, awareness of this gene’s role has grown as rare variants were linked to epilepsy, developmental differences, and learning challenges in some children and adults. Early reports focused on seizure patterns and developmental features seen in families and individual patients. Over time, descriptions became more precise as genetic testing made it easier to connect these shared features to the same gene. This shift helped define SLC6A1-related neurodevelopmental condition as a recognized diagnosis in clinical genetics.